BIOKIN PHARMACEUTICAL(SH:688506) Xin Lang Cai Jing·2025-09-03 05:49Group 1 - The core viewpoint of the news is that Baili Tianheng's stock has experienced a significant increase, with a 5.09% rise on September 3, reaching a price of 379.98 yuan per share, and a cumulative increase of 11.57% over three consecutive days [1] - Baili Tianheng Pharmaceutical Co., Ltd. is located in Chengdu, Sichuan Province, and was established on August 17, 2006, with its listing date on January 6, 2023. The company focuses on the research, production, and sales of pharmaceuticals [1] - The company's main business revenue is composed of 99.57% recognized at a specific point in time and 0.43% recognized over a specific period [1] Group 2 - From the perspective of fund holdings, the Jiao Yin Schroder Fund has a significant position in Baili Tianheng, with the Jiao Yin Medical Health Mixed Fund A (019345) holding 5,086 shares, accounting for 2.96% of the fund's net value, ranking as the tenth largest holding [2] - During the three-day increase, the fund has realized a floating profit of approximately 19.07 thousand yuan, with a current floating profit of about 9.36 thousand yuan [2] - The Jiao Yin Medical Health Mixed Fund A (019345) was established on October 11, 2023, with a latest scale of 31.87 million yuan and has achieved a year-to-date return of 71.33% [2]